Results 171 to 180 of about 8,420 (208)
Some of the next articles are maybe not open access.

RP-HPLC In-Vitro Dissolution Method Development and Validation for Determination of Olmesartan Medoxomil, Chlorthalidone & Cilnidipine Drug Combinations

Current Pharmaceutical Analysis, 2022
A simple, sensitive, and accurate in-vitro dissolution method has been developed for Olmesartan Medoxomil (OLM), Chlorthalidone (CHLR) & Cilnidipine (CIL) drug combination according to USP dissolution testing methodologies with different discriminating
Pranavkumar Shah, B. Dhaduk
semanticscholar   +1 more source

Forced Degradation Products of Olmesartan Medoxomil and their In Vitro Genotoxicity Assessment by Comet Assay using HEK Cells

ChemistrySelect
This study designed to characterize major forced degradation products of Olmesartan Medoxomil (OM) and to perform genotoxicity profiling using acid, base, and hydrogen peroxide‐induced stress degradation studies. The isolation of degradation products was
Shrutika Wankhade   +5 more
semanticscholar   +1 more source

Pharmacokinetics and Bioequivalence Evaluation of 2 Olmesartan Medoxomil and Amlodipine Besylate Fixed‐Dose Combination Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions

Clinical pharmacology in drug development, 2022
Combined antihypertensive drugs have become the basic method of treating hypertension. Olmesartan and amlodipine, as representative drugs of angiotensin receptor blockers and calcium channel blockers, were developed as a compound formulation for ...
Xinjing Li, En Mo, Lin Chen
semanticscholar   +1 more source

An Investigative Review for PharmaceuticalAnalysis of Angiotensin receptor blockers: Olmesartan Medoxomil.

Annales Pharmaceutiques Françaises
Hypertension is often asymptomatic and can substantially elevate the risk of cardiovascular complications. Olmesartan medoxomil works by competitively blocking the angiotensin II receptors, preventing angiotensin II from constructing the blood vessels ...
Vinod A. Chaure, A. Shirkhedkar
semanticscholar   +1 more source

Formulation and evaluation of Olmesartan Medoxomil nanosuspension

Materials Today: Proceedings, 2023
S. Ahirrao   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy